MoonLake Immunotherapeutics
Ticker(s):
MLTX
Country:
Sector & Industry:
Business Overview
MoonLake Immunotherapeutics, a clinical stage biopharmaceutical company, engages in developing therapies. The company develops Sonelokimab, a novel tri-specific investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Contact & Other Information
Number of Employees:
100
Website:
Dorfstrasse 29
Zug
,
,
6300
Switzerland
41 415108022
No content was found.